L. Gabrie

SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19–Seropositive Individuals

E. López-Granados, F. Sánchez‐Madrid, S. Prat, 2020, The Journal of Immunology.

SARS-Cov-2 cysteine-like protease (Mpro) is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals

E. López-Granados, F. Sánchez‐Madrid, S. Prat, 2020, medRxiv.

COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes.

J. Soriano, F. Sánchez‐Madrid, I. González-Álvaro, 2020, The Journal of clinical investigation.

Differential Redistribution of Activated Monocyte and Dendritic Cell Subsets to the Lung Associates with Severity of COVID-19

J. Soriano, F. Sánchez‐Madrid, I. González-Álvaro, 2020, medRxiv.

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

T. Cavero, F. Sánchez‐Madrid, I. González-Álvaro, 2020, Journal of Allergy and Clinical Immunology.

Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients

F. Sánchez‐Madrid, M. López-Trascasa, I. González-Álvaro, 2020, medRxiv.

Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients

F. Sánchez‐Madrid, I. González-Álvaro, M. Orts, 2021, Scientific Reports.